Joanne Kurtzberg, MD

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Joanne Kurtzberg, MD sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials 1 currently recruiting 13 completed early-phase tilt top decile by trial count

Joanne Kurtzberg, MD: 15 sponsored US clinical trials, 1 recruiting.

Joanne Kurtzberg, MD sponsors 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 0 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism, with 2 trials.

Top-decile sponsor footprint

Joanne Kurtzberg, MD ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 72/100

13 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

15 total, page 1 of 1

RECRUITING Phase 1

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

NCT02254863
COMPLETED Phase 1

hCT-MSC Infusion in Adults With Autism Spectrum Disorder

NCT04484077
COMPLETED Phase 1

Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis

NCT04943289
COMPLETED Phase 2

hCT-MSC in Children With Autism Spectrum Disorder

NCT04089579
TERMINATED Phase 1

hCT-MSCs for COVID19 ARDS

NCT04399889
COMPLETED Phase 1

Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE

NCT03635450
COMPLETED Phase 1

A Study of UCB and MSCs in Children With CP: ACCeNT-CP

NCT03473301
COMPLETED Phase 1

hCT-MSCs for Children With Autism Spectrum Disorder (ASD)

NCT03099239
COMPLETED Phase 2

Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke

NCT03004976
COMPLETED Phase 2

Cord Blood Infusion for Children With Autism Spectrum Disorder

NCT02847182
COMPLETED Phase 1

Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy

NCT02599207
COMPLETED Phase 1

Cord Blood Infusion for Ischemic Stroke

NCT02397018
COMPLETED Phase 2

A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy

NCT01147653
COMPLETED Phase 1

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

NCT00673114
COMPLETED Phase 1

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

NCT00692926

Phase Distribution

PhaseTrial count
Phase 1 11
Phase 2 4

Therapeutic Areas

Autism 2
Autism Spectrum Disorder 2
Congenital Immunodeficiency Syndrome 1
Congenital Marrow Failure 1
PDD 1
Anemia, Aplastic 1
Neimann Pick Disease 1
Leukodystrophy, Metachromatic 1
Leukodystrophy, Globoid Cell 1
Sandhoff Disease 1

What is open in the Joanne Kurtzberg, MD pipeline

1 recruiting of 15 indexed (7% open); 13 completed (87%).

Phase mix: 0 late (III/IV) vs 15 early (I/II) (early-phase heavy).

Top condition: Autism (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Joanne Kurtzberg, MD: open-pipeline peers nationwide

Peers matched on 15 registered trials and 7% open enrollment, not the therapeutic-area sidebar.

Joanne Kurtzberg, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 14.914.91515.1 0%10%20%30%40% Total trials Recruiting share Joanne Kurtzberg, MDAllakosArbor Research Collaborative for HealthArena PharmaceuticalsArrowhead PharmaceuticalsBaylor Breast Care CenterGeron CorporationGuerbetLakefront Biotherapeutics
Joanne Kurtzberg, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Joanne Kurtzberg, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 trials (± recruiting share)

Sponsors near 7% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Joanne Kurtzberg, MD page

15 registered trials is a research-attention snapshot, not an endorsement of Joanne Kurtzberg, MD or any single study.

  • 1 of Joanne Kurtzberg, MD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autism is the condition Joanne Kurtzberg, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Joanne Kurtzberg, MD pipeline card: 15 registered trials from official public datasets.Report a data error.